Relationship between Obesity and Hypercholesterolemia

Salwa Muftah Eljamay

doi:10.64516/8snt3t35

Authors

Salwa Muftah Eljamay Department of public Health, Faculty of Medical Technology, Derna City , Libya. Author

DOI:

https://doi.org/10.64516/8snt3t35

Keywords:

Cholesterol,, Obesity,, Hypercholesterolemia,, Nutrition,, Carbohydrate.

Abstract

The aim of this study was to evaluate the association between serum cholesterol level and body Obesity in Derna City, and to investigate the trend of the prevalence of obesity in Derna and its relationship with hypercholesterolemia. The study was a cross-sectional study carried out on the 66 (40 males and 26 females) weight between 65 – 135 kg, which were selected using multistage cluster sampling method. Plasma cholesterol was measured in the morning after a 12-hour fasting and was determined by auto-analyzer. Hypercholesterolemia (HC) was defined by a total plasma cholesterol level over 200 mg/dl. That the percent of males was 40( 60.6% ), and the percent of female was 26( 39.4% ), Ranges weights of the people who took them samples were, from 55kg to 135 kg, the percent of less weight was (7.6% ) . The weights that were above normal weight rate was from 86kg to 135kg by (28.79% ), The percent of cholesterol levels ranged between 90mg\dl to 350mg\dl, The percentage of people who increased their cholesterol were 7(10.6%), the percent and the type of Nutrition, that was, fat, vegetable, fruits, and carbohydrate. The highest proportion of fat by 31(47.0 %) , and less percentage of fruit by,8 (12.1%), The rate of Heart disease in the people and there percent were, 13 ( 19.7 %), the people did not have heart disease were 53( 80.3%), and the proportion of smokers from non-smokers were, smokers 17(25.8 %), non smoking 49(74.2 %). I note that the Mean and Std. deviation of the weight was 3.0 (Std, 1.478), and the quality of nutrition was 2.11(Std .1.229), smoking was1.74, (Std. 0.441), and heart disease1.80 (Std.0, 401).

References

1. Durrington, P (2003). "Dyslipidaemia". The Lancet 362 (9385): 717– 31.

2. Melissa C, Jerry R. B . (2012). 1996-2013 Medicine Net, Source quiz on Medicine Net.

3.Biggerstaff KD, Wooten JS, 2004, "Understanding lipoproteins as transporters of cholesterol and other lipids". Adv Physiol Educ 28 (1–4): 105 6.

4.Carmena R, Duriez P, Fruchart JC (2004), "Atherogenic lipoprotein particles in atherosclerosis".Circulation 109 (23 Suppl 1): III2– 7.

5.Kontush A, Chapman MJ, (2006). "Antiatherogenic small, dense HDL-- guardian angel of the arterial wall?". Nat Clin Pract Cardiovasc Med 3 (3): 144–53.

6.Hooper L, Summerbell CD, Thompson R,et al.(2012). "Reduced or modified dietary fat for prevening cardiovascular disease". In Hooper, Lee.Cochrane Database Syst Rev5: CD002137.

7.Ito MK, McGowan MP, Moriarty PM, (2011), "Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia". J Clin Lipidol 5 (3 Suppl): S38–45.

8.Bhatnagar D, Soran H, Durrington PN ,(2008), "Hypercholesterolaemia and its management". BMJ337: a993. doi:10.1136/bmj.a993.

9.Finn AV, Nakano M, Narula J, 9.Kolodgie FD, Virmani R (2010). "Concept of vulnerable/unstable plaque".Arterioscler. Thromb. Vasc. Biol.30(7): 1282 92.

10. Grundy, SM; Balady, GJ; Criqui, MH; Fletcher, G; Greenland, P; Hiratzka, LF; Houston-Miller, N; Kris-Etherton, P (1998). "Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association". Circulation 97(18): 1876–87.

10. Shields, C; Shields, J, (2008). Eyelid, conjunctival, and orbital tumors: atlas and textbook. Hagerstown, Maryland: Lippincott Williams & Wilkins. ISBN 0-7817-7578-7.

11. Zech LA Jr, Hoeg JM, (2008), "Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia". Lipids Health Dis 7: 7.

12. James, WD; Berger, TG (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. pp. 530–2. ISBN 0-7216-2921-0.

13. Rapini, RP; Bolognia, JL; Jorizzo, JL, (2007). Dermatology: 2-Volume Set. St. Louis, Missouri: Mosby. pp. 1415–6.ISBN 1-4160-2999-0.

15.Howell WH, McNamara DJ, Tosca MA, Smith BT, Gaines JA (1997). "Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis". Am. J. Clin. Nutr. 65 (6): 1747–64.

16.AH (1990). "Intestinal cholesterol metabolism".Ann. Med.22(1): 49– 52.

17. Stryer, Lubert; Berg, Jeremy Mark; Tymoczko, John L. (2007). Biochemistry. San Francisco: W.H. Freeman.ISBN 0-7167-8724-5.

18. Sacks FM, Katan M , (2002), "Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease". Am. J. Med. 113 Suppl 9B: 13S–24S.

19. Schaefer, EJ; Gleason, JA; Dansinger, ML (2009)."Dietary fructose and glucose differentially affect lipid and glucose homeostasis". The Journal of nutrition 139 (6):1257S 1262S.

20.Consumer Reports. (2013). Drug Effectiveness Review Project :"Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price".

21. Grundy, SM; Balady, GJ; Criqui, MH; Fletcher, G; Greenland, P; Hiratzka, LF; Houston-Miller, N; Kris-Etherton, P (1998). "Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association". Circulation 97(18): 1876–87.

22. Reiner Z, Catapano AL, De Backer G, et al.(2011). "ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)".Eur. Heart J.32(14): 1769– 818.

23. Pignone, M, (2005). "Primary prevention: dyslipidaemia".Clin Evid (14): 142–50. Retrieved 2010-11-04.

24. Gami, A (2006). "Secondary prevention of ischaemic cardiac events". Clin Evid (15): 195–228.PMID 16973010. Retrieved 2010-11-04.

25. Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA (1998). "Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects". BMJ 316 (7139): 1213– 20.

26.National Institute for Health and Clinical Excellence.Clinical guideline 67: Lipid modification. London, 2008.

27. Snow V, Aronson M, Hornbake E, Mottur-Pilson C, Weiss K (2004). "Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians".Ann Intern Med 140 (8):6449.

28. Vijan,S;Hayward, RA; American CollegeOf,Physicians (2004). "Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians". Ann InternMed 140 (8):650–8.

29. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake

DB, Pasternak RC, Smith SC, Stone NJ (2004). "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel IIIGuidelines". JAmCollCardiol 44 (3):72032.

30. Hayward, RA; Hofer, TP; Vijan, S (2006). "Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem".Ann Intern Med145(7): 520–30.

31.Nazir Ahmed, Waqas Anwar*, Huma Waqas Department of Medicine, *Department of Dermatology, Frontier Medical College, Abbottabad, Department of Paediatrics, Women Medical College, Abbottabad, Pakistan,J Ayub Med Coll Abbottabad 2009;21(4) OBESITY, HYPERLIPIDEMIA, AND HYPERURAECEMIA IN YOUNG AND OLD HYPERTENSIVE PATIENTS

32.Andrew M Tershakovec, Abbas F Jawad, Nicole O Stouffer, Abdalla Elkasabany, Sathanur R Srinivasan, and Gerald S Berenson, Am J Clin Nutr 2002;76:730–5. Printed in USA. © 2002 American Society for Clinical Nutrition, Persistent hypercholesterolemia is associated with thedevelopment of obesity among girls: the Bogalusa Heart Study1–3.

33.Journal Eur Heart J. (2013. [Epub ahead of print]Affiliation Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, DK-2730 Herlev, Copenhagen, Denmark. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society.

34.Pećin I, Sućur N, Reiner Z.Journal Lijec Vjesn. (2013). Familial hypercholesterolemia - do we think enough about this severe disease?]. Article in Croatian, 135(5-6):145-9.

35. Guidance for clinicians to prevent coronary heart disease. (2013). Consensus Statement of the European Atherosclerosis Society. Eur Heart J.

36.Pećin I, Sućur N, Reiner Z. (2013). Journal Lijec Vjesn.;135(5-6):145-9. do we think enough about this severe disease.

37.Ahmed W, Whittall R, Riaz M, Ajmal M, Sadeque A, Ayub H, Qamar R, Humphries SE. (2013). The genetic spectrum of familial hypercholesterolemia in Pakistan. Journal Clin Chim Acta: 5;421:219-25.

38.Hypercholesterolemia | University of Maryland Medical Center. (2018). http://umm.edu/health/medical/altmed/condition/hypercholesterolemia#ixzz

2i6EQuZd1.

39.kylenorton, (2011). Obesity and Hyperlipidemia ( High Levels of Cholesterol and Triglycerides).

40. Gholamreza V, Mehdi S, Hamidraza J, Samieh B, Pooneh, Abdolhamid A, Ebrahim T, Abbas M. (2013). Obesity and risk of hypercholesterolemia in Iranian northern adults, Vol 9, No 1.